- Filed
- May 6, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 27, 2026 | 41.63M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 42.59M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 47.96M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $50.29M |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $37.66M |
| Capex | Q1 2026 · Mar 31, 2026 | $468K |
| Capex | Q1 2026 · Mar 31, 2025 | $765K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $85.24M |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2025 | $94.54M |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $470M |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $199M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $67.18M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $112.65M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $696.95M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $689.8M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $829.69M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $789.78M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $9.2B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $8.66B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $9.9B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $9.35B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $1.41 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $1.19 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $1.43 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $1.21 |
| Net Income | Q1 2026 · Mar 31, 2026 | $60.07M |
| Net Income | Q1 2026 · Mar 31, 2025 | $57.17M |